CN107744142A - 一种具有润肠和安神作用的保健蜜丸 - Google Patents
一种具有润肠和安神作用的保健蜜丸 Download PDFInfo
- Publication number
- CN107744142A CN107744142A CN201711043927.3A CN201711043927A CN107744142A CN 107744142 A CN107744142 A CN 107744142A CN 201711043927 A CN201711043927 A CN 201711043927A CN 107744142 A CN107744142 A CN 107744142A
- Authority
- CN
- China
- Prior art keywords
- drying
- black garlic
- benevolence
- health care
- honeyed bolus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 206010010774 Constipation Diseases 0.000 title claims abstract description 46
- 230000036541 health Effects 0.000 title claims abstract description 35
- 230000001624 sedative effect Effects 0.000 title claims abstract description 26
- 241000383638 Allium nigrum Species 0.000 claims abstract description 74
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 48
- 229940029982 garlic powder Drugs 0.000 claims abstract description 41
- 244000223082 Syzygium paniculatum Species 0.000 claims abstract description 32
- 235000016641 Syzygium paniculatum Nutrition 0.000 claims abstract description 32
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 29
- 235000012907 honey Nutrition 0.000 claims abstract description 29
- 240000007049 Juglans regia Species 0.000 claims abstract description 25
- 235000009496 Juglans regia Nutrition 0.000 claims abstract description 24
- 235000020234 walnut Nutrition 0.000 claims abstract description 24
- 241000218236 Cannabis Species 0.000 claims abstract description 21
- 239000000463 material Substances 0.000 claims abstract description 18
- 238000012545 processing Methods 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 239000000835 fiber Substances 0.000 claims abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 67
- 239000002002 slurry Substances 0.000 claims description 48
- 238000001035 drying Methods 0.000 claims description 35
- 210000000582 semen Anatomy 0.000 claims description 28
- 239000000843 powder Substances 0.000 claims description 25
- 230000005070 ripening Effects 0.000 claims description 25
- 239000006187 pill Substances 0.000 claims description 24
- 239000012141 concentrate Substances 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 18
- 239000003814 drug Substances 0.000 claims description 16
- 230000008569 process Effects 0.000 claims description 15
- 235000013399 edible fruits Nutrition 0.000 claims description 14
- 239000012535 impurity Substances 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 14
- 241001504664 Crossocheilus latius Species 0.000 claims description 12
- 238000007605 air drying Methods 0.000 claims description 12
- 238000009835 boiling Methods 0.000 claims description 12
- 238000007796 conventional method Methods 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- 238000004108 freeze drying Methods 0.000 claims description 10
- 241000256844 Apis mellifera Species 0.000 claims description 4
- 238000001704 evaporation Methods 0.000 claims description 4
- 230000008020 evaporation Effects 0.000 claims description 4
- 238000001694 spray drying Methods 0.000 claims description 4
- 240000008866 Ziziphus nummularia Species 0.000 claims description 3
- 235000007215 black sesame Nutrition 0.000 claims description 2
- 238000000227 grinding Methods 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 238000007873 sieving Methods 0.000 claims description 2
- 230000008901 benefit Effects 0.000 abstract description 4
- 230000002650 habitual effect Effects 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 4
- 238000011161 development Methods 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 3
- 235000016709 nutrition Nutrition 0.000 abstract description 3
- 230000000050 nutritive effect Effects 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract 1
- 240000005809 Prunus persica Species 0.000 description 19
- 230000000694 effects Effects 0.000 description 18
- 239000000047 product Substances 0.000 description 15
- 230000006870 function Effects 0.000 description 13
- 241000196324 Embryophyta Species 0.000 description 12
- 239000004575 stone Substances 0.000 description 11
- 239000002253 acid Substances 0.000 description 9
- 230000009471 action Effects 0.000 description 7
- 210000000936 intestine Anatomy 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 230000007958 sleep Effects 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- -1 linoleic acid, leukotrienes Chemical class 0.000 description 6
- 230000000144 pharmacologic effect Effects 0.000 description 6
- 240000002234 Allium sativum Species 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 235000004611 garlic Nutrition 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- VGGSULWDCMWZPO-ODEMIOGVSA-N spinosin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=2C(=O)C=C(OC=2C=C1OC)C=1C=CC(O)=CC=1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VGGSULWDCMWZPO-ODEMIOGVSA-N 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical compound N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 3
- DBOVHQOUSDWAPQ-UHFFFAOYSA-N (4aS)-6c-[O2-(3,5,3'-trihydroxy-biphenyl-2-carbonyl)-beta-D-glucopyranosyloxy]-5t-vinyl-(4ar)-4,4a,5,6-tetrahydro-3H-pyrano[3,4-c]pyran-1-one Natural products OC1C(O)C(CO)OC(OC2C(C3C(C(OCC3)=O)=CO2)C=C)C1OC(=O)C1=C(O)C=C(O)C=C1C1=CC=CC(O)=C1 DBOVHQOUSDWAPQ-UHFFFAOYSA-N 0.000 description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 3
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 3
- BZXINCMCFVKGKB-UHFFFAOYSA-N Amarogentin Natural products OCC1OC(OC2OC=C3C(CCOC3=O)C2C=C)C(OC(=O)c4cc(O)cc(O)c4c5cccc(O)c5)C(O)C1O BZXINCMCFVKGKB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
- 239000005642 Oleic acid Substances 0.000 description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 3
- 241001290151 Prunus avium subsp. avium Species 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 229930182558 Sterol Natural products 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- DBOVHQOUSDWAPQ-WTONXPSSSA-N amarogentin Chemical compound O([C@H]1[C@H](O[C@H]2[C@@H]([C@H]3C(C(OCC3)=O)=CO2)C=C)O[C@@H]([C@H]([C@@H]1O)O)CO)C(=O)C1=C(O)C=C(O)C=C1C1=CC=CC(O)=C1 DBOVHQOUSDWAPQ-WTONXPSSSA-N 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 235000019693 cherries Nutrition 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- VGGSULWDCMWZPO-UHFFFAOYSA-N flavoayamenin Natural products COC1=CC=2OC(C=3C=CC(O)=CC=3)=CC(=O)C=2C(O)=C1C1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O VGGSULWDCMWZPO-UHFFFAOYSA-N 0.000 description 3
- 230000001077 hypotensive effect Effects 0.000 description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- 235000021313 oleic acid Nutrition 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 150000003432 sterols Chemical class 0.000 description 3
- 235000003702 sterols Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- OSELKOCHBMDKEJ-UHFFFAOYSA-N (10R)-3c-Hydroxy-10r.13c-dimethyl-17c-((R)-1-methyl-4-isopropyl-hexen-(4c)-yl)-(8cH.9tH.14tH)-Delta5-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(=CC)C(C)C)C1(C)CC2 OSELKOCHBMDKEJ-UHFFFAOYSA-N 0.000 description 2
- MCWVPSBQQXUCTB-UHFFFAOYSA-N (24Z)-5alpha-Stigmasta-7,24(28)-dien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(=CC)C(C)C)CCC33)C)C3=CCC21 MCWVPSBQQXUCTB-UHFFFAOYSA-N 0.000 description 2
- AKXOIHNFHOEPHN-CQSZACIVSA-N (6ar)-1-methoxy-6-methyl-5,6,6a,7-tetrahydro-4h-dibenzo[de,g]quinoline-2-ol Chemical compound C([C@H]1N(C)CC2)C3=CC=CC=C3C3=C1C2=CC(O)=C3OC AKXOIHNFHOEPHN-CQSZACIVSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- XXLFLUJXWKXUGS-UHFFFAOYSA-N 6-methoxyquinoline-4-carboxylic acid Chemical compound N1=CC=C(C(O)=O)C2=CC(OC)=CC=C21 XXLFLUJXWKXUGS-UHFFFAOYSA-N 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- WWNNZCOKKKDOPX-UHFFFAOYSA-N N-methylnicotinate Chemical compound C[N+]1=CC=CC(C([O-])=O)=C1 WWNNZCOKKKDOPX-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 241000220317 Rosa Species 0.000 description 2
- 206010039897 Sedation Diseases 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 2
- 206010000891 acute myocardial infarction Diseases 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000003276 anti-hypertensive effect Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 235000000431 campesterol Nutrition 0.000 description 2
- 235000001122 chang geng bian tao Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 235000019439 ethyl acetate Nutrition 0.000 description 2
- 239000010685 fatty oil Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000036280 sedation Effects 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 229940032091 stigmasterol Drugs 0.000 description 2
- 235000016831 stigmasterol Nutrition 0.000 description 2
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 1
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- BNOGJEJAYILSFT-XNSRJBNMSA-N 1(F)-alpha-D-galactosylraffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@]1(O[C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1)O)CO[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 BNOGJEJAYILSFT-XNSRJBNMSA-N 0.000 description 1
- BVMGAUOJVUEFSV-UHFFFAOYSA-N 1-(oxan-2-yl)indazol-6-amine Chemical compound C12=CC(N)=CC=C2C=NN1C1CCCCO1 BVMGAUOJVUEFSV-UHFFFAOYSA-N 0.000 description 1
- WECGLUPZRHILCT-GSNKCQISSA-N 1-linoleoyl-sn-glycerol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC[C@@H](O)CO WECGLUPZRHILCT-GSNKCQISSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- KKAJSJJFBSOMGS-UHFFFAOYSA-N 3,6-diamino-10-methylacridinium chloride Chemical compound [Cl-].C1=C(N)C=C2[N+](C)=C(C=C(N)C=C3)C3=CC2=C1 KKAJSJJFBSOMGS-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
- BSLYZLYLUUIFGZ-JRUDBKCSSA-N 4,4,14-trimethyl-9,19-cyclo-5alpha,9beta-cholestane Chemical compound C1CCC(C)(C)[C@H]2[C@@]31C[C@@]13CC[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@]3(C)[C@@H]1CC2 BSLYZLYLUUIFGZ-JRUDBKCSSA-N 0.000 description 1
- SMRPGWBDLOQHOS-UHFFFAOYSA-N 5-[4,5-dihydroxy-6-(hydroxymethyl)-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxy-3,4-dihydroxy-6-[[9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1H-picen-3-yl]oxy]oxane-2-carboxylic acid Chemical compound OC1C(O)C(O)C(C)OC1OC1C(OC2C(OC(C(O)C2O)C(O)=O)OC2C(C3C(C4C(C5(CCC6(C)C(O)CC(C)(C)CC6C5=CC4=O)C)(C)CC3)(C)CC2)(C)CO)OC(CO)C(O)C1O SMRPGWBDLOQHOS-UHFFFAOYSA-N 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- 108010007828 Allantoinase Proteins 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 241000169680 Aphloia theiformis Species 0.000 description 1
- 241000256846 Apis cerana Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 244000080767 Areca catechu Species 0.000 description 1
- 235000006226 Areca catechu Nutrition 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 229910052684 Cerium Inorganic materials 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 244000276331 Citrus maxima Species 0.000 description 1
- 235000001759 Citrus maxima Nutrition 0.000 description 1
- 108010069514 Cyclic Peptides Proteins 0.000 description 1
- 102000001189 Cyclic Peptides Human genes 0.000 description 1
- RRTBTJPVUGMUNR-UHFFFAOYSA-N Cycloartanol Natural products C12CCC(C(C(O)CC3)(C)C)C3C2(CC)CCC2(C)C1(C)CCC2C(C)CCCC(C)C RRTBTJPVUGMUNR-UHFFFAOYSA-N 0.000 description 1
- 235000018783 Dacrycarpus dacrydioides Nutrition 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 101000783577 Dendroaspis angusticeps Thrombostatin Proteins 0.000 description 1
- 101000783578 Dendroaspis jamesoni kaimosae Dendroaspin Proteins 0.000 description 1
- 240000003421 Dianthus chinensis Species 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- UIOFUWFRIANQPC-JKIFEVAISA-N Floxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl UIOFUWFRIANQPC-JKIFEVAISA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 108010059881 Lactase Proteins 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- OSEGOMJCJRKRPD-UHFFFAOYSA-N Lychnose Natural products OCC1OC(O)C(OCC2(OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O)OC(CO)C(O)C2O)C(O)C1O OSEGOMJCJRKRPD-UHFFFAOYSA-N 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 240000007711 Peperomia pellucida Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 240000007263 Pinus koraiensis Species 0.000 description 1
- 235000008578 Pinus strobus Nutrition 0.000 description 1
- NIBVDXPSJBYJFT-VBBCUDLLSA-N Planteose Natural products O(C[C@@H]1[C@H](O)[C@@H](O)[C@@](O[C@@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)(CO)O1)[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1 NIBVDXPSJBYJFT-VBBCUDLLSA-N 0.000 description 1
- 241000220299 Prunus Species 0.000 description 1
- 235000008104 Prunus humilis Nutrition 0.000 description 1
- 241000057271 Prunus humilis Species 0.000 description 1
- 241000436215 Prunus pedunculata Species 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000612118 Samolus valerandi Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 241000220287 Sedum rubrotinctum Species 0.000 description 1
- LUSZGTFNYDARNI-UHFFFAOYSA-N Sesamol Natural products OC1=CC=C2OCOC2=C1 LUSZGTFNYDARNI-UHFFFAOYSA-N 0.000 description 1
- ZZMNWJVJUKMZJY-UHFFFAOYSA-N Sesamolin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3OC2=CC=C3OCOC3=C2)=C1 ZZMNWJVJUKMZJY-UHFFFAOYSA-N 0.000 description 1
- ZZMNWJVJUKMZJY-AFHBHXEDSA-N Sesamolin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3OC2=CC=C3OCOC3=C2)=C1 ZZMNWJVJUKMZJY-AFHBHXEDSA-N 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- OZWDYLLMBFLSNH-UHFFFAOYSA-N Swertisin Natural products COc1cc2OC(=CC(=O)c2c(O)c1OC3OC(CO)C(O)C(O)C3O)c4cccc(O)c4 OZWDYLLMBFLSNH-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000002300 anti-fibrosis Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940127218 antiplatelet drug Drugs 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical group C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- YNBJLDSWFGUFRT-UHFFFAOYSA-N cycloartenol Natural products CC(CCC=C(C)C)C1CCC2(C)C1(C)CCC34CC35CCC(O)C(C)(C)C5CCC24C YNBJLDSWFGUFRT-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 229940085633 glyceryl linolenate Drugs 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine Substances NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 229940116108 lactase Drugs 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 229910052746 lanthanum Inorganic materials 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000003446 memory effect Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 229940095674 pellet product Drugs 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- NIBVDXPSJBYJFT-ZQSKZDJDSA-N planteose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1 NIBVDXPSJBYJFT-ZQSKZDJDSA-N 0.000 description 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- GGJRAQULURVTAJ-PDBXOOCHSA-N rac-1-alpha-linolenoylglycerol Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(=O)OCC(O)CO GGJRAQULURVTAJ-PDBXOOCHSA-N 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000001034 respiratory center Anatomy 0.000 description 1
- PPRSVUXPYPBULA-UHFFFAOYSA-N saponin A Natural products CC1(C)CCC2(CCC3(C)C(=CCC4C5(C)CCC(OC6OC(CO)C(O)C(O)C6=O)C(C)(C)C5CCC34C)C2C1)C(=O)O PPRSVUXPYPBULA-UHFFFAOYSA-N 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- IZEUIYYDWBKERE-UHFFFAOYSA-N stigmasteryl acetate Natural products C1C=C2CC(OC(C)=O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 IZEUIYYDWBKERE-UHFFFAOYSA-N 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- ABRULANJVVJLFI-DGHBBABESA-N swertisin Chemical compound COC1=CC=2OC(C=3C=CC(O)=CC=3)=CC(=O)C=2C(O)=C1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ABRULANJVVJLFI-DGHBBABESA-N 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
- A23L21/25—Honey; Honey substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
- A23L25/30—Mashed or comminuted products, e.g. pulp, pastes, meal, powders; Products made therefrom, e.g. blocks, flakes, snacks; Liquid or semi-liquid products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Botany (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Insects & Arthropods (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于保健食品领域。具体公开了一种具有润肠和安神作用的保健蜜丸，该蜜丸是由以下比例原料加工制成；黑大蒜粉：黑之麻：大麻仁：酸枣仁：郁李仁：桃仁：核桃仁:炼蜜为2.0:1.0:0.5:1.5:1.0:0.5:1.5:7‑8；本发明产品不仅从原料配伍中起到润肠安神作用，且具有上述物料营养成分的营养功效，为解决中老年人习惯性便秘提供了一种新的产品，产品具有较好的应用前景，对促进养老事业的发展有一定的社会效益。
Description
技术领域
本发明涉及保健食品领域，具体涉及一种具有润肠安神作用的保健蜜丸。
背景技术
随着社会老龄化人口不断增加，关爱老人健康已上升到国家管理层面。随着老人生活的安逸和活动减少，大便秘结已成为大多老年人口的突出现象，伴随而来的精神压力增大，影响正常生活规律进而影响睡眠，给老年人的健康带来一定的影响。为了使老年人有一个健康、快乐、幸福的晚年生活，提高老龄人口的保健意识，减少或避免因上述因素需长期服用药品，从既是食品又是药品且具有保健功效的物品中，寻找具有润肠功能和具有安神效果的物品组成一种具有保健作用的制品，对解决老年人健康保健的需要十分重要，开发一种既能解决老年人因胃肠功能减弱而引起的便秘，同时又能起到安神作用，使老年人有一良好的睡眠条件，同时又能对老年人的健康起到有益作用的保健制品，这对我国养老事业的健康发展会直到一个良好的社会效益。
发明内容
本发明的目的是提供一种具有润肠和安神作用的蜜丸。
本发明的目的是由以下技术方案实现
一种具有润肠和安神作用的保健蜜丸，其特征是由以下重量比例的黑大蒜粉、黑芝麻、火麻仁、酸枣仁、郁李仁、桃仁、核桃仁和炼蜜为原料，以黑大蒜粉：黑芝麻：火麻仁：酸枣仁：郁李仁：桃仁：核桃仁：炼蜜为2.0：1.0：0.5：1.5：1.0：0.5：1.5：7-8比例按以下方法制得：（1）首先取黑大蒜在50℃-90℃条件下，干燥至含水量小于2%；（2）将干燥后的黑大蒜冷却至室温、粉碎，粉碎后的黑大蒜粉过200-300目筛，得到黑大蒜粉备用；（3）取干燥成熟的黑芝麻，取火麻仁，除去杂质，筛去灰屑，将酸枣仁晒干，碾去核壳，取净仁，将郁李仁碾碎果核，取种仁，将净桃仁置沸水中，加热至种皮微鼓起，捞出，置凉水中浸泡，取出，搓开种皮与种仁，干燥，除去种皮，将干燥成熟的核桃，砸破果壳取种仁；（4）将处理后的原料按配方比例称取各原料混合，加水常温浸泡3小时后，捞出，置于磨浆机中，按原料重量的10倍加水打磨成浆液，过100目筛，将浆液置于锅内先大火煮沸15min，再转小火继续煮40min，得浆料；（5）将步骤（4）得到的浆料在50℃-75℃、-0.065MPa～-0.1MPa条件下，浓缩至比重为1.25，得浓缩液；（6）将步骤（5）所得浓缩液采用喷雾干燥或冷冻干燥使含水量在3%以下，经粉碎，过100目筛，得物料粉；（7）将步骤（6）所得物料粉与步骤（2）得到的黑大蒜粉混合，搅拌均匀，加入温度为65℃-75℃的炼蜜，经常规方法进行和药，制丸块，搓条，制丸等工序制成每丸重9克的蜜丸；所述的炼蜜是将蜂蜜置锅中，加热溶化后，过筛除去死蜂及浮沫等杂质，再加入锅内继续加热至116-118℃，煮沸至含水量在14-16%，比重为1.36-1.38即得。
根据本发明，优选的工艺条件如下：
上述步骤（1）所述的干燥，优选的干燥条件为在70℃-80℃条件下，干燥至含水量小于2%。
上述步骤（1）所述的干燥采用热风干燥、远红外干燥或微波干燥。
上述步骤（2）所述的粉碎为超微粉碎，优选使用振动超微粉碎机。
上述步骤（5）中优选的浓缩条件为60℃-70℃、-0.065MPa～-0.09MPa。
上述步骤（5）所述的浓缩选用真空旋转蒸发器、管式蒸发浓缩器或板式蒸发浓缩器。
本发明以上所述设备均为本领域常规设备。
一种由权利要求1所述的具有润肠和安神作用的保健蜜丸的制备方法。
黑大蒜是经过高温高湿的环境，自然发酵而制得，经过大蒜自身的物理化学变化，不仅使口味酸甜，食用不会产生难闻的口气，而多酚与游离氨基酸的含量大大超过生蒜，同时产生了艾桥恩及S-烯丙基半胱氨酸，水溶性抗氧化物质是普通大蒜的8.7倍，脂溶性抗氧化物质是生蒜的79倍，有增强人体免疫力、抗过敏、抗衰老、抗癌、抑制动脉硬化、平稳血压、降血脂、降血糖、降低胆固醇、治疗便秘、美容等功效。黑大蒜在市场的销售中，由于其对老年人习惯性便秘的功效十分显著，故黑大蒜商品市场很受欢迎。本发明中所述的黑大蒜原料均由徐州绿之野生物食品有限公司加工生产的商品级黑大蒜为基本原料。本发明将黑大蒜经低温干燥后粉碎成超微粉，利于食用后在胃肠道的分布和吸收。
黑芝麻，市售商品，为脂麻科脂麻属植物芝麻Sesanum indicum L.的干燥成熟种子。具文献报导，其化学成分种子含脂肪油，油中主要为油酸、亚油酸、软脂酸、硬脂酸、肉豆蔻酸等脂肪酸的甘油酯。此外，尚含有芝麻素、芝麻酚、芝麻林酚素、组氨酸、色氨酸、车前糖及剪秋罗糖、甾醇类。其药理作用：（1）降血糖等作用：大鼠口服种子提取物可降低血糖，增加肝脏及肌肉中的糖原含量；（2）延缓衰老作用：给予黑芝麻的小鼠与对照组比较，衰老现象推迟发生。功能与主治：滋补肝肾，养血润肠，通乳。适用于肝肾不足，头晕目眩，贫血，便秘，乳汁缺乏。
火麻仁，市售商品，火麻仁为桑科大麻属植物大麻Cannabis sativa L.的干燥成熟果实。火麻仁的化学成分含有饱合脂肪酸，油酸、亚油酸、亚麻酸、葫芦巴碱、异亮氨基酸甜菜碱、白色毒素、毒素、植物酸钙镁，此外尚含蛋白质、维生素B1、B2、胆碱、挥发油、卵磷脂、菜油甾醇、β-谷甾醇、麦角甾醇等。据文献介绍，火麻仁具有（1）镇痛抗炎作用；（2）致泻作用；（3）抗溃疡作用；（4）抗衰老作用；（5）改善学习和记忆作用；（6）降血压作用等药理作用。火麻仁性味；甘，平。功能与主治：润燥滑肠。适用于血虚津亏，肠燥便秘。
酸枣仁，市售商品，酸枣仁为鼠李科枣属植物酸枣Ziziphus jujubaMill.var.spinosua Bunge的干燥成熟种子。其化学成分含生物碱:酸枣仁碱A、B、D、E、F、G1、G2、Ja、Jb、K、N-甲基巴婆碱、酸李碱、观音连明碱等；三帖类：白桦脂酸、罗珠子酸甲酯、白桦脂醇，酸枣仁皂苷A、A1、B、G等；含黄酮类：当药素、斯皮诺素、异斯皮诺素、6＂阿魏酰基斯皮诺素、酸枣黄素、6＂对香豆酰基斯皮诺素、芹菜素-6-C-β-D-葡萄糖苷等。此外还含有苏氨酸、蛋氨酸、亮氨酸、阿魏酸、植物甾醇、枣仁环肽等成分。据文献报导，酸枣仁具有（1）镇静、抗惊厥作用；（2）镇痛作用；（3）降温作用；（4）降血压作用；（5）抗心律失常作用；（6）降血脂作用等药理作用。酸枣仁性味：甘、酸，平。功能主治：养心，安神，敛汗。适用于神经衰弱，失眠，多梦，心悸，盗汗。
郁李仁，市售商品。郁李仁为蔷薇科樱桃属植物欧李Prunus humili Bge、郁李Prunusjaponico Thunb.或长柄扁桃Prunus Pedunculata Maxim的干燥成熟种子。其化学成分：欧李和郁李的种仁均含苦杏仁苷、郁李仁苷；脂肪油及有机酸等。据文献介绍，其药理作用具有：（1）利尿、泻下作用，欧李有利尿、缓下作用；郁李糖苷对实验动物有强烈的泻下作用。（2）降血压作用：郁李仁有显著的降压作用。（3）郁李糖苷有镇静作用。郁李仁性味：辛、苦、甘，平。功能主治：润肠通便，下气利水。适用于津枯肠燥，食积气滞，腹胀便秘，水肿，脚气，小便不利等。
桃仁，市售商品。桃仁为蔷薇科樱桃属植物桃Prunus Ptisico（L.）Batsch或山桃Prunusdauidiana（Carr.）franch.的干燥成熟种子。其化学成分，种仁含苦杏仁苷、苦杏仁酶、尿囊素酶、乳糖酶、维生素B1、脂肪油等；还含精油：苯甲醛、柠檬烯、1-甲乙基肼、石竹烯、罗勒烯等；蛋白质成分；PR-A、PR-B；不饱和脂肪酸：油酸、亚油酸等；甾醇类成分： △7-豆甾烯醇乙酸酯、β-谷甾醇乙酸酯、菜油甾醇乙酸酯、豆甾醇乙酸酯、 △5-燕麦甾醇乙酸酯等；三萜醇类成分：羽扇醇乙酸酯、24-亚甲基环阿屯烷醇乙酸酯等。果肉含桃苷、柚素、儿茶素、奎宁酸、番茄红、胡萝卜素。据文献记载，桃仁具有以下药理作用：（1）抗纤维化作用；（2）对心血管系统的作用，桃仁对体外兔耳血管能明显增加灌流液的流量，并能消除去甲肾上腺素的缩血管作用；桃仁石油醚提取物能降低急性心肌梗死大鼠心电图ST段的抬高，抑制血清中CPK、LDH的升高，降低冠状动脉结扎造成的急性心肌梗死大鼠的梗死面积；桃仁煎剂对离体蛙心呈抑制，并有短暂的降压作用。抗血栓作用：桃仁在体内、外对以凝血酶和ADP诱导的血小板聚集均有明显的抑制作用，是一个有效的多途径血小板聚集抑制剂。镇咳作用：桃仁含苦杏仁苷，能分离出氢氰酸；氢氰酸对呼吸中枢呈镇静作用，因此有止咳的功效。其他作用：桃仁含大量脂肪油，故有润肠之效。桃仁性味：苦、甘，平。功能主治：活血祛瘀，润肠通便，止咳平喘。适用于经闭痛经，瘕瘕痞块，肺痈肠痈，跌打损伤，肠燥便秘，咳嗽气喘。
核桃仁，市售商品。核桃仁为胡桃科胡桃属植物胡桃Juglans regia L.的干燥成熟种子。核桃仁含脂肪油：亚油酸甘油酯、油酸甘油酯、亚麻酸甘油酯；甾醇类成分：油菜甾醇、豆甾醇、谷甾醇、△5-燕麦甾醇、△7-豆甾醇等；氨基酸，异白氨酸、白氨酸、色氨酸等；矿物质元素：钙、磷、铁等；维生素：维生素B2、a-维生素E、r-维生素E等；还含蛋白质、磷脂、胡萝卜素等。现代文献记载有以下药理作用：（1）抗衰老作用；（2）抗氧化作用，核桃蛋白肽有抗氧化作用，随着核桃蛋白肽浓度的增加，其还原能力、羟基自由基的消除能力和超氧阴离子清除能力增大。核桃仁性味：甘，温。功能与主治：补肾，温肺，润肠。适用于肾阳不足，腰膝酸软，阳痿遗精，虚寒喘嗽，肠燥便秘。
蜂蜜，市售商品。蜂蜜为蜜蜂科昆虫中华蜜蜂Apis cerana Fabr.或意大利蜂Apismellifera L.所酿的蜜。蜂蜜富含转化糖、挥发油、蜡质、有机酸、花粉粒，并且含泛酸、烟酸、乙酰胆碱、维生素A、维生素D、维生素E等。尚含有淀粉酶、蔗糖转化酶、葡萄糖氧化酶、过氧化氢酶、酸性磷酸脂酶、多种氨基酸、Ca、Fe、Zn、Mn、Cu、Se、Mo等微量元素，以及La、Ce等稀土元素。蜂蜜具有（1）对创面有收敛、营养和促进愈合的作用。（2）有润滑性祛痰和缓泻作用。（3）能清除体内自由基，有抗氧化作用等药理作用。蜂蜜性味：甘，平。功能主治：补中，润燥，止痛，解毒；适用于腔腹虚痛，肺燥干咳，肠燥便秘等。
本发明利用本公司加工生产黑大蒜的优势，根据市场销售信息反馈收集整理，其对黑大蒜的食用对象，占＞60%的人群是用于防治便秘而在服用，对此，企业研发课题组，经过对具有润燥润肠功能的中药进行筛选，结合中老年人睡眠减少，睡眠易醒等普遍现象，采用黑大蒜配合黑芝麻、火麻仁、酸枣仁、郁李仁、桃仁、核桃仁以及炼蜜组成一种具有润肠和安神功能的保健蜜丸，本发明不仅从原料的配伍中起到润肠安神作用，且具有上述物料营养成分的营养功效，发明产品比单独食用黑大蒜具有更好的食用效果，且提供了多方面的营养需求，为解决中老年人习惯性便秘提供了一种新的产品，具有很好的应用前景，对保障人们健康养老提供了一种食用方便，无毒付作用的良好产品，对促进养老事业的发展具有一定的促进作用，产品的市场化，具有很好的社会效益。
本发明产品，服用方便，口味甘甜清香，特别配方中加入了比例量的炼蜜，不仅是作为蜜丸的最好助剂同时还对肠燥便秘具有协同的良好功效，同时也是一种营养补品，对人体的健康起到了其它甜味剂无法可替代的良好效果。
本发明产品经过对患有习惯性便秘的中老年人45例食用统计，其效十分满意，试验人数45例，其中男性30人，女性15人，年龄50-55岁20人，60以上25人，其中6人年龄大于70岁，45例试验人群中，有16人在应用本发明蜜丸产品前，长期口服果导片，其他均有不定时服用中、西药品的习惯。45人中，有35人每天服用本发明产品2次，早、晚各一次，每次1丸，其中10人每天晚饭后服一次，每次2丸，结果显示，有42人大便变软，排便顺畅，无秘结感。本发明产品对防治老年人便秘有效率达93.33%。上述试验人员在服用本发明产品过程中未出现拉稀、下泻症状，未发现其他不良反应，试用人员口述自身体会时，均认为该产品效果好，无不良反应，其中36人均认为夜间睡眠好，睡的深沉，食量增加，肠蠕动好，排便顺畅。本发明产品为丸剂产品，携带使用均较方便，利于人们的食用。
具体实施方式
下面结合实施例对本发明的一种具有润肠和安神作用的保健蜜丸的制作工艺方法作进一步的说明，而非本发明的全部。
实施例1
一种具有润肠和安神作用的保健蜜丸，其制备方法如下：
（1）首先取黑大蒜采用热风干燥箱内，在70℃条件下热风干燥至含水量小于2%；
（2）将步骤（1）干燥后的黑大蒜取出，冷却至室温，使用振动超微粉碎机粉碎，粉碎后的黑大蒜粉过200目振动筛，制得黑大蒜粉，备用；
（3）取干燥成熟的黑芝麻，取火麻仁，除去杂质，筛去灰屑，将酸枣仁晒干，碾去核壳，取净仁，将郁李仁碾碎果核，取种仁，将净桃仁置沸水中加热至种皮微鼓起，捞出，置凉水中浸泡，取出，搓开种皮与种仁，干燥，除去种皮，将干燥成熟的核桃，砸破果壳取种仁；
（4）称取经处理后的黑芝麻1kg，火麻仁0.5kg，酸枣仁1.5kg，郁李仁1kg，桃仁0.5kg，核桃仁1.5kg混合，加水常温浸泡3小时后，捞出，加入60kg水用磨浆机打磨成浆液，过100目筛，将浆液倾入锅内，先用大火煮沸15min，再转小火继续煮40min，得浆料；
（5）将步骤（4）得到的浆料，用真空旋转蒸发器，在60℃、-0.09MPa条件下浓缩至比重为1.25，得浓缩液；
（6）将步骤（5）所得浓缩液采用喷雾干燥器进行喷雾干燥使含水量在3%以下，经粉碎，过100目筛，得物料粉；
（7）将步骤（6）所得物料粉与步骤（2）得到的黑大蒜粉2kg混合，搅拌均匀，加入温度为65℃、权利要求1所述的炼蜜8kg，经常规方法进行和药，制丸块，搓条，制丸等工序制成每丸重9克的蜜丸，即得。
实施例2
一种具有润肠和安神作用的保健蜜丸，其制备方法如下：
（1）首先取黑大蒜采用热风干燥箱内，在80℃条件下热风干燥至含水量小于2%；
（2）将步骤（1）干燥后的黑大蒜取出，冷却至室温，使用振动超微粉碎机粉碎，粉碎后的黑大蒜粉过300目振动筛，制得黑大蒜粉，备用；
（3）取干燥成熟的黑芝麻，取火麻仁，除去杂质，筛去灰屑，将酸枣仁晒干，碾去核壳，取净仁，将郁李仁碾碎果核，取种仁，将净桃仁置沸水中加热至种皮微鼓起，捞出，置凉水中浸泡，取出，搓开种皮与种仁，干燥，除去种皮，将干燥成熟的核桃，砸破果壳取种仁；
（4）称取经处理后的黑芝麻1kg，火麻仁0.5kg，酸枣仁1.5kg，郁李仁1kg，桃仁0.5kg，核桃仁1.5kg混合，加水常温浸泡3小时后，捞出，加入60kg水用磨浆机打磨成浆液，过100目筛，将浆液倾入锅内，先用大火煮沸15min，再转小火继续煮40min，得浆料；
（5）将步骤（4）得到的浆料，用真空旋转蒸发器、在70℃、-0.065MPa条件下浓缩至比重为1.25，得浓缩液；
（6）将步骤（5）所得浓缩液采用喷雾干燥器进行喷雾干燥使含水量在3%以下，经粉碎，过100目筛，得物料粉；
（7）将步骤（6）所得物料粉与步骤（2）得到的黑大蒜粉2kg混合，搅拌均匀，加入温度为75℃、权利要求1所述的炼蜜7kg，经常规方法进行和药，制丸块，搓条，制丸等工序制成每丸重9克的蜜丸，即得。
实施例3
一种具有润肠和安神作用的保健蜜丸，其制备方法如下：
（1）首先取黑大蒜采用热风干燥箱内，在75℃条件下热风干燥至含水量小于2%；
（2）将步骤（1）干燥后的黑大蒜取出，冷却至室温，使用振超微动粉碎机粉碎，粉碎后的黑大蒜粉过250目振动筛，制得黑大蒜粉，备用；
（3）取干燥成熟的黑芝麻，取火麻仁，除去杂质，筛去灰屑，将酸枣仁晒干，碾去核壳，取净仁，将郁李仁碾碎果核，取种仁，将净桃仁置沸水中加热至种皮微鼓起，捞出，置凉水中浸泡，取出，搓开种皮与种仁，干燥，除去种皮，将干燥成熟的核桃，砸破果壳取种仁；
（4）称取经处理后的黑芝麻1kg，火麻仁0.5kg，酸枣仁1.5kg，郁李仁1kg，桃仁0.5kg，核桃仁1.5kg混合，加水常温浸泡3小时后，捞出，加入60kg水用磨浆机打磨成浆液，过100目筛，将浆液倾入锅内，先用大火煮沸15min，再转小火继续煮40min，得浆料；
（5）将步骤（4）得到的浆料，用真空旋转蒸发器、在65℃、-0.075MPa条件下浓缩至比重为1.25，得浓缩液；
（6）将步骤（5）所得浓缩液采用冷冻干燥机进行冷冻干燥使含量在3%以下，经粉碎，过100目筛，得物料粉；
（7）将步骤（6）所得物料粉与步骤（2）得到的黑大蒜粉2kg混合，搅拌均匀，加入温度为70℃、权利要求1所述的炼蜜7.5kg，经常规方法进行和药，制丸块，搓条，制丸等工序制成每丸重9克的蜜丸，即得。
实施例4
一种具有润肠和安神作用的保健蜜丸，其制备方法如下：
（1）首先取黑大蒜采用热风干燥箱内，在75℃条件下热风干燥至含水量小于2%；
（2）将步骤（1）干燥后的黑大蒜取出，冷却至室温，使用振超微动粉碎机粉碎，粉碎后的黑大蒜粉过250目振动筛，制得黑大蒜粉，备用；
（3）取干燥成熟的黑芝麻，取火麻仁，除去杂质，筛去灰屑，将酸枣仁晒干，碾去核壳，取净仁，将郁李仁碾碎果核，取种仁，将净桃仁置沸水中加热至种皮微鼓起，捞出，置凉水中浸泡，取出，搓开种皮与种仁，干燥，除去种皮，将干燥成熟的核桃，砸破果壳取种仁；
（4）称取经处理后的黑芝麻1kg，火麻仁0.5kg，酸枣仁1.5kg，郁李仁1kg，桃仁0.5kg，核桃仁1.5kg混合，加水常温浸泡3小时后，捞出，加入60kg水用磨浆机打磨成浆液，过100目筛，将浆液倾入锅内，先用大火煮沸15min，再转小火继续煮40min，得浆料；
（5）将步骤（4）得到的浆料，用真空旋转蒸发器、在65℃、-0.075MPa条件下浓缩至比重为1.25，得浓缩液；
（6）将步骤（5）所得浓缩液采用冷冻干燥机进行冷冻干燥使含量在3%以下，经粉碎，过100目筛，得物料粉；
（7）将步骤（6）所得物料粉与步骤（2）得到的黑大蒜粉2kg混合，搅拌均匀，加入温度为70℃、权利要求1所述的炼蜜7.5kg，经常规方法进行和药，制丸块，搓条，制丸等工序制成每丸重9克的蜜丸，即得。
实施例5
一种具有润肠和安神作用的保健蜜丸，其制备方法如下：
（1）首先取黑大蒜采用热风干燥箱内，在75℃条件下热风干燥至含水量小于2%；
（2）将步骤（1）干燥后的黑大蒜取出，冷却至室温，使用振超微动粉碎机粉碎，粉碎后的黑大蒜粉过250目振动筛，制得黑大蒜粉，备用；
（3）取干燥成熟的黑芝麻，取火麻仁，除去杂质，筛去灰屑，将酸枣仁晒干，碾去核壳，取净仁，将郁李仁碾碎果核，取种仁，将净桃仁置沸水中加热至种皮微鼓起，捞出，置凉水中浸泡，取出，搓开种皮与种仁，干燥，除去种皮，将干燥成熟的核桃，砸破果壳取种仁；
（4）称取经处理后的黑芝麻1kg，火麻仁0.5kg，酸枣仁1.5kg，郁李仁1kg，桃仁0.5kg，核桃仁1.5kg混合，加水常温浸泡3小时后，捞出，加入60kg水用磨浆机打磨成浆液，过100目筛，将浆液倾入锅内，先用大火煮沸15min，再转小火继续煮40min，得浆料；
（5）将步骤（4）得到的浆料，用真空旋转蒸发器、在65℃、-0.075MPa条件下浓缩至比重为1.25，得浓缩液；
（6）将步骤（5）所得浓缩液采用冷冻干燥机进行冷冻干燥使含量在3%以下，经粉碎，过100目筛，得物料粉；
（7）将步骤（6）所得物料粉与步骤（2）得到的黑大蒜粉2kg混合，搅拌均匀，加入温度为70℃、权利要求1所述的炼蜜7.5kg，经常规方法进行和药，制丸块，搓条，制丸等工序制成每丸重9克的蜜丸，即得。
实施例6
一种具有润肠和安神作用的保健蜜丸，其制备方法如下：
（1）首先取黑大蒜采用热风干燥箱内，在75℃条件下热风干燥至含水量小于2%；
（2）将步骤（1）干燥后的黑大蒜取出，冷却至室温，使用振超微动粉碎机粉碎，粉碎后的黑大蒜粉过250目振动筛，制得黑大蒜粉，备用；
（3）取干燥成熟的黑芝麻，取火麻仁，除去杂质，筛去灰屑，将酸枣仁晒干，碾去核壳，取净仁，将郁李仁碾碎果核，取种仁，将净桃仁置沸水中加热至种皮微鼓起，捞出，置凉水中浸泡，取出，搓开种皮与种仁，干燥，除去种皮，将干燥成熟的核桃，砸破果壳取种仁；
（4）称取经处理后的黑芝麻1kg，火麻仁0.5kg，酸枣仁1.5kg，郁李仁1kg，桃仁0.5kg，核桃仁1.5kg混合，加水常温浸泡3小时后，捞出，加入60kg水用磨浆机打磨成浆液，过100目筛，将浆液倾入锅内，先用大火煮沸15min，再转小火继续煮40min，得浆料；
（5）将步骤（4）得到的浆料，用真空旋转蒸发器、在65℃、-0.075MPa条件下浓缩至比重为1.25，得浓缩液；
（6）将步骤（5）所得浓缩液采用冷冻干燥机进行冷冻干燥使含量在3%以下，经粉碎，过100目筛，得物料粉；
（7）将步骤（6）所得物料粉与步骤（2）得到的黑大蒜粉2kg混合，搅拌均匀，加入温度为70℃、权利要求1所述的炼蜜7.5kg，经常规方法进行和药，制丸块，搓条，制丸等工序制成每丸重9克的蜜丸，即得。
实施例7
一种具有润肠和安神作用的保健蜜丸，其制备方法如下：
（1）首先取黑大蒜采用热风干燥箱内，在75℃条件下热风干燥至含水量小于2%；
（2）将步骤（1）干燥后的黑大蒜取出，冷却至室温，使用振超微动粉碎机粉碎，粉碎后的黑大蒜粉过250目振动筛，制得黑大蒜粉，备用；
（3）取干燥成熟的黑芝麻，取火麻仁，除去杂质，筛去灰屑，将酸枣仁晒干，碾去核壳，取净仁，将郁李仁碾碎果核，取种仁，将净桃仁置沸水中加热至种皮微鼓起，捞出，置凉水中浸泡，取出，搓开种皮与种仁，干燥，除去种皮，将干燥成熟的核桃，砸破果壳取种仁；
（4）称取经处理后的黑芝麻1kg，火麻仁0.5kg，酸枣仁1.5kg，郁李仁1kg，桃仁0.5kg，核桃仁1.5kg混合，加水常温浸泡3小时后，捞出，加入60kg水用磨浆机打磨成浆液，过100目筛，将浆液倾入锅内，先用大火煮沸15min，再转小火继续煮40min，得浆料；
（5）将步骤（4）得到的浆料，用真空旋转蒸发器、在65℃、-0.075MPa条件下浓缩至比重为1.25，得浓缩液；
（6）将步骤（5）所得浓缩液采用冷冻干燥机进行冷冻干燥使含量在3%以下，经粉碎，过100目筛，得物料粉；
（7）将步骤（6）所得物料粉与步骤（2）得到的黑大蒜粉2kg混合，搅拌均匀，加入温度为70℃、权利要求1所述的炼蜜7.5kg，经常规方法进行和药，制丸块，搓条，制丸等工序制成每丸重9克的蜜丸，即得。
实施例8
一种具有润肠和安神作用的保健蜜丸，其制备方法如下：
（1）首先取黑大蒜采用热风干燥箱内，在75℃条件下热风干燥至含水量小于2%；
（2）将步骤（1）干燥后的黑大蒜取出，冷却至室温，使用振超微动粉碎机粉碎，粉碎后的黑大蒜粉过250目振动筛，制得黑大蒜粉，备用；
（3）取干燥成熟的黑芝麻，取火麻仁，除去杂质，筛去灰屑，将酸枣仁晒干，碾去核壳，取净仁，将郁李仁碾碎果核，取种仁，将净桃仁置沸水中加热至种皮微鼓起，捞出，置凉水中浸泡，取出，搓开种皮与种仁，干燥，除去种皮，将干燥成熟的核桃，砸破果壳取种仁；
（4）称取经处理后的黑芝麻1kg，火麻仁0.5kg，酸枣仁1.5kg，郁李仁1kg，桃仁0.5kg，核桃仁1.5kg混合，加水常温浸泡3小时后，捞出，加入60kg水用磨浆机打磨成浆液，过100目筛，将浆液倾入锅内，先用大火煮沸15min，再转小火继续煮40min，得浆料；
（5）将步骤（4）得到的浆料，用真空旋转蒸发器、在65℃、-0.075MPa条件下浓缩至比重为1.25，得浓缩液；
（6）将步骤（5）所得浓缩液采用冷冻干燥机进行冷冻干燥使含量在3%以下，经粉碎，过100目筛，得物料粉；
（7）将步骤（6）所得物料粉与步骤（2）得到的黑大蒜粉2kg混合，搅拌均匀，加入温度为70℃、权利要求1所述的炼蜜7.5kg，经常规方法进行和药，制丸块，搓条，制丸等工序制成每丸重9克的蜜丸，即得。
实施例9
一种具有润肠和安神作用的保健蜜丸，其制备方法如下：
（1）首先取黑大蒜采用热风干燥箱内，在75℃条件下热风干燥至含水量小于2%；
（2）将步骤（1）干燥后的黑大蒜取出，冷却至室温，使用振超微动粉碎机粉碎，粉碎后的黑大蒜粉过250目振动筛，制得黑大蒜粉，备用；
（3）取干燥成熟的黑芝麻，取火麻仁，除去杂质，筛去灰屑，将酸枣仁晒干，碾去核壳，取净仁，将郁李仁碾碎果核，取种仁，将净桃仁置沸水中加热至种皮微鼓起，捞出，置凉水中浸泡，取出，搓开种皮与种仁，干燥，除去种皮，将干燥成熟的核桃，砸破果壳取种仁；
（4）称取经处理后的黑芝麻1kg，火麻仁0.5kg，酸枣仁1.5kg，郁李仁1kg，桃仁0.5kg，核桃仁1.5kg混合，加水常温浸泡3小时后，捞出，加入60kg水用磨浆机打磨成浆液，过100目筛，将浆液倾入锅内，先用大火煮沸15min，再转小火继续煮40min，得浆料；
（5）将步骤（4）得到的浆料，用真空旋转蒸发器、在65℃、-0.075MPa条件下浓缩至比重为1.25，得浓缩液；
（6）将步骤（5）所得浓缩液采用冷冻干燥机进行冷冻干燥使含量在3%以下，经粉碎，过100目筛，得物料粉；
（7）将步骤（6）所得物料粉与步骤（2）得到的黑大蒜粉2kg混合，搅拌均匀，加入温度为70℃、权利要求1所述的炼蜜7.5kg，经常规方法进行和药，制丸块，搓条，制丸等工序制成每丸重9克的蜜丸，即得。
实施例10
一种具有润肠和安神作用的保健蜜丸，其制备方法如下：
（1）首先取黑大蒜采用热风干燥箱内，在75℃条件下热风干燥至含水量小于2%；
（2）将步骤（1）干燥后的黑大蒜取出，冷却至室温，使用振超微动粉碎机粉碎，粉碎后的黑大蒜粉过250目振动筛，制得黑大蒜粉，备用；
（3）取干燥成熟的黑芝麻，取火麻仁，除去杂质，筛去灰屑，将酸枣仁晒干，碾去核壳，取净仁，将郁李仁碾碎果核，取种仁，将净桃仁置沸水中加热至种皮微鼓起，捞出，置凉水中浸泡，取出，搓开种皮与种仁，干燥，除去种皮，将干燥成熟的核桃，砸破果壳取种仁；
（4）称取经处理后的黑芝麻1kg，火麻仁0.5kg，酸枣仁1.5kg，郁李仁1kg，桃仁0.5kg，核桃仁1.5kg混合，加水常温浸泡3小时后，捞出，加入60kg水用磨浆机打磨成浆液，过100目筛，将浆液倾入锅内，先用大火煮沸15min，再转小火继续煮40min，得浆料；
（5）将步骤（4）得到的浆料，用真空旋转蒸发器、在65℃、-0.075MPa条件下浓缩至比重为1.25，得浓缩液；
（6）将步骤（5）所得浓缩液采用冷冻干燥机进行冷冻干燥使含量在3%以下，经粉碎，过100目筛，得物料粉；
（7）将步骤（6）所得物料粉与步骤（2）得到的黑大蒜粉2kg混合，搅拌均匀，加入温度为70℃、权利要求1所述的炼蜜7.5kg，经常规方法进行和药，制丸块，搓条，制丸等工序制成每丸重9克的蜜丸，即得。
Claims (5)
1.一种具有润肠和安神作用的保健蜜丸，其特征是由以下重量比例的黑大蒜粉、黑芝麻、火麻仁、酸枣仁、郁李仁、桃仁、核桃仁和炼蜜为原料，以黑大蒜粉：黑芝麻：火麻仁：酸枣仁：郁李仁：桃仁：核桃仁：炼蜜为2.0：1.0：0.5：1.5：1.0：0.5：1.5：7-8比例按以下方法制得：（1）首先取黑大蒜在50℃-90℃条件下，干燥至含水量小于2%；（2）将干燥后的黑大蒜冷却至室温、粉碎，粉碎后的黑大蒜粉过200-300目筛，得到黑大蒜粉备用；（3）取干燥成熟的黑芝麻，取火麻仁，除去杂质，筛去灰屑，将酸枣仁晒干，碾去核壳，取净仁，将郁李仁碾碎果核，取种仁，将净桃仁置沸水中，加热至种皮微鼓起，捞出，置凉水中浸泡，取出，搓开种皮与种仁，干燥，除去种皮，将干燥成熟的核桃，砸破果壳取种仁；（4）将处理后的原料按配方比例称取各原料混合，加水常温浸泡3小时后，捞出，置于磨浆机中，按原料重量的10倍加水打磨成浆液，过100目筛，将浆液置于锅内先大火煮沸15min，再转小火继续煮40min，得浆料；（5）将步骤（4）得到的浆料在50℃-75℃、-0.065MPa～-0.1MPa条件下，浓缩至比重为1.25，得浓缩液；（6）将步骤（5）所得浓缩液采用喷雾干燥或冷冻干燥使含水量在3%以下，经粉碎，过100目筛，得物料粉；（7）将步骤（6）所得物料粉与步骤（2）得到的黑大蒜粉混合，搅拌均匀，加入温度为65℃-75℃的炼蜜，经常规方法进行和药，制丸块，搓条，制丸等工序制成每丸重9克的蜜丸；所述的炼蜜是将蜂蜜置锅中，加热溶化后，过筛除去死蜂及浮沫等杂质，再加入锅内继续加热至116-118℃，煮沸至含水量在14-16%，比重为1.36-1.38即得。
2.如权利要求1所述的一种具有润肠和安神作用的保健蜜丸，其特征在于：所述步骤（1）所述的干燥采用热风干燥、远红外干燥或微波干燥；优选的干燥条件为在70℃-80℃；所述步骤（2）所述的粉碎为超微粉碎。
3.如权利要求2所述的一种具有润肠和安神作用的保健蜜丸，其特征在于：所述的超微粉碎，优选使用振动超微粉碎机。
4.如权利要求1所述的一种具有润肠和安神作用的保健蜜丸，其特征在于：所述步骤（5）所述的浓缩使用真空旋转蒸发器、管式蒸发浓缩器或板式蒸发浓缩器；优选的浓缩条件为60℃-70℃、-0.065MPa～-0.09MPa。
5.一种如权利要求1-4任一项所述的具有润肠和安神作用的保健蜜丸的制备方法。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711043927.3A CN107744142A (zh) | 2017-10-31 | 2017-10-31 | 一种具有润肠和安神作用的保健蜜丸 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711043927.3A CN107744142A (zh) | 2017-10-31 | 2017-10-31 | 一种具有润肠和安神作用的保健蜜丸 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107744142A true CN107744142A (zh) | 2018-03-02 |
Family
ID=61253714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711043927.3A Withdrawn CN107744142A (zh) | 2017-10-31 | 2017-10-31 | 一种具有润肠和安神作用的保健蜜丸 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107744142A (zh) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101524149A (zh) * | 2009-04-20 | 2009-09-09 | 杜胜岳 | 中老年强身健体营养蜂蜜及配制方法 |
| CN103191234A (zh) * | 2013-02-22 | 2013-07-10 | 周涛 | 一种麻仁丸 |
| CN103520678A (zh) * | 2013-10-14 | 2014-01-22 | 张桂赫 | 补虚定惊丸 |
| CN106605900A (zh) * | 2015-10-20 | 2017-05-03 | 汤衍斌 | 一种黑蒜软胶囊 |
| CN106923123A (zh) * | 2017-03-22 | 2017-07-07 | 佛山迁宇科技有限公司 | 一种五仁玫瑰通便饮料及其制备方法 |
-
2017
- 2017-10-31 CN CN201711043927.3A patent/CN107744142A/zh not_active Withdrawn
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101524149A (zh) * | 2009-04-20 | 2009-09-09 | 杜胜岳 | 中老年强身健体营养蜂蜜及配制方法 |
| CN103191234A (zh) * | 2013-02-22 | 2013-07-10 | 周涛 | 一种麻仁丸 |
| CN103520678A (zh) * | 2013-10-14 | 2014-01-22 | 张桂赫 | 补虚定惊丸 |
| CN106605900A (zh) * | 2015-10-20 | 2017-05-03 | 汤衍斌 | 一种黑蒜软胶囊 |
| CN106923123A (zh) * | 2017-03-22 | 2017-07-07 | 佛山迁宇科技有限公司 | 一种五仁玫瑰通便饮料及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100574635C (zh) | 沙棘果皮食品基料及其加工方法和应用 | |
| KR101738594B1 (ko) | 흑도라지청 및 이의 제조방법 | |
| CN101797346B (zh) | 降血压降血脂降血糖七清中药茶及其制备方法 | |
| CN105901715A (zh) | 一种鹿胶糕及其制备方法 | |
| CN105707313A (zh) | 一种降三高柳青叶茶组合物及其制备方法 | |
| CN109730180A (zh) | 一种降血压、降血脂、降血糖组合物及其制备方法和袋泡茶 | |
| CN110122803A (zh) | 一种诺丽果片及其制备方法 | |
| CN112618691A (zh) | 一种具有补气血功效的中药组合物及其制备方法和应用 | |
| CN101658210A (zh) | 一种苏麻油及其制备方法和应用 | |
| CN108850319A (zh) | 一种具有保健养生功能速溶茶粉的制备方法 | |
| CN109275856A (zh) | 一种灵芝食品 | |
| CN112471513A (zh) | 一种黄精蜜丸的制作方法 | |
| CN107047864A (zh) | 慢性咽炎调理保健茶及其制备方法 | |
| CN106265785A (zh) | 一种沙棘抑郁症胶囊及其生产工艺 | |
| CN107744142A (zh) | 一种具有润肠和安神作用的保健蜜丸 | |
| CN105286003A (zh) | 一种用于改善肥胖和便秘的组合物及其制备方法 | |
| CN112007121B (zh) | 治疗绝经综合征的口服冲剂及其制备工艺 | |
| KR102240938B1 (ko) | 환성 건강식품 및 그 제조방법 | |
| CN107822015A (zh) | 一种具有润肠和安神作用的保健食品 | |
| CN108013459A (zh) | 一种具有减肥美容功能的保健食品及其制备方法 | |
| CN104137999B (zh) | 一种瘦身减肥的食疗组合物和辅料制得的保健品及其制备方法 | |
| CN106085765A (zh) | 一种健脾润肺养生酒及其制备方法 | |
| CN102715508B (zh) | 复方核桃软胶丸强化营养品 | |
| CN110651983A (zh) | 一种高蛋白营养粉及其制备方法 | |
| CN109156778A (zh) | 一种铁皮石斛山楂糕及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| CB02 | Change of applicant information |
Address after: Three No. 1, No. 221300, Pizhou hi tech Industrial Development Zone, Jiangsu, Xuzhou, China Applicant after: Xuzhou Lvzhiye Biological Food Co., Ltd. Address before: 221300 Jiangsu city of Xuzhou province Pizhou City, Su Yang Town High Road No. 1 Applicant before: Xuzhou Lvzhiye Biological Food Co., Ltd. |
|
| CB02 | Change of applicant information | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20180302 |
|
| WW01 | Invention patent application withdrawn after publication |